Brendan Winslow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brendan Winslow
Brendan Winslow is recorded as CFO at Atrium Therapeutics, Inc. (RNA). Atrium Therapeutics, Inc. reported in an 8-K filed February 27, 2026 that Brendan Winslow was appointed Chief Financial Officer. Brendan Winslow has spoken on 1 investor event across 1 company, most recently for Atrium Therapeutics, Inc. on September 8, 2026.
“You will serve as the Company's Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atrium Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carsten Boess Board Member
- Simona Skerjanec Board Member
- Troy Wilson Board Member
- W. Michael Flanagan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.